First Time Loading...

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 38.28 USD 0.29% Market Closed
Updated: May 31, 2024

Revolution Medicines Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Revolution Medicines Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Revolution Medicines Inc
NASDAQ:RVMD
Depreciation & Amortization
$6.1m
CAGR 3-Years
18%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.6B
CAGR 3-Years
2%
CAGR 5-Years
37%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
$2.7B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
18%
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$4.6B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$196m
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$435.6m
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
26%

See Also

What is Revolution Medicines Inc's Depreciation & Amortization?
Depreciation & Amortization
6.1m USD

Based on the financial report for Dec 31, 2023, Revolution Medicines Inc's Depreciation & Amortization amounts to 6.1m USD.

What is Revolution Medicines Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
28%

Over the last year, the Depreciation & Amortization growth was 21%. The average annual Depreciation & Amortization growth rates for Revolution Medicines Inc have been 18% over the past three years , 28% over the past five years .